Page last updated: 2024-11-07
rubiadin 1-methyl ether
Description
Rubiadin 1-methyl ether is a natural product isolated from various plant species, including Rubia tinctorum. It exhibits a range of biological activities, including antioxidant, anti-inflammatory, and anti-cancer properties. Research has shown its potential as a therapeutic agent for treating conditions like cancer and inflammatory diseases. Its unique chemical structure, characterized by a quinone moiety and a methoxy group, contributes to its biological activity. Studies have explored its synthesis through various methods, including chemical and enzymatic approaches, to understand its structure-activity relationship and develop synthetic analogs with enhanced properties.'
```
rubiadin 1-methyl ether: structure given in first source; isolated from the stem bark and roots of Morinda lucida [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Morinda | genus | A plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.[MeSH] | Rubiaceae | The Madder plant family of the order Gentianales (formerly Rubiales), subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.[MeSH] |
| Morinda lucida | species | [no description available] | Rubiaceae | The Madder plant family of the order Gentianales (formerly Rubiales), subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.[MeSH] |
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 96191 |
| CHEMBL ID | 3921530 |
| SCHEMBL ID | 16227041 |
| MeSH ID | M0211999 |
Synonyms (28)
| Synonym |
|---|
| rubiadin-1-methyl ether |
| 3-hydroxy-1-methoxy-2-methyl-anthraquinone |
| 3-hydroxy-1-methoxy-2-methyl-anthracene-9,10-dione |
| nsc-59063 |
| 7460-43-7 |
| nsc59063 |
| NCIOPEN2_002551 |
| rubiadin 1-methyl ether |
| 3-hydroxy-1-methoxy-2-methylanthracene-9,10-dione |
| unii-mk2ixh6aue |
| nsc 59063 |
| 9,10-anthracenedione, 3-hydroxy-1-methoxy-2-methyl- |
| mk2ixh6aue , |
| AKOS015897180 |
| DTXSID80225572 |
| AC-34253 |
| FT-0698923 |
| SCHEMBL16227041 |
| 1-methoxy-2-methyl-3-hydroxy-anthrachinon |
| 3-hydroxy-1-methoxy-2-methylanthraquinone |
| CHEMBL3921530 |
| CS-0018274 |
| HY-N1956 |
| F17682 |
| mfcd12031637 |
| anthraquinone, 3-hydroxy-1-methoxy-2-methyl- |
| 3-hydroxy-1-methoxy-2-methyl-9,10-anthracenedione |
| MS-23789 |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.75 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.95 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |